Fc. Krebs et al., Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: Comparative sensitivity of primary human vaginal keratinocytes, ANTIM AG CH, 44(7), 2000, pp. 1954-1960
A broad-spectrum vaginal microbicide must be effective against a variety of
sexually transmitted disease pathogens and be minimally toxic to the cell
types found within the vaginal epithelium, including vaginal keratinocytes.
We assessed the sensitivity of primary human vaginal keratinocytes to pote
ntial topical vaginal microbicides nonoxynol-9 (N-9), C31G, and sodium dode
cyl sulfate (SDS). Direct immunofluorescence and fluorescence-activated cel
l sorting analyses demonstrated that primary vaginal keratinocytes expresse
d epithelial cell-specific keratin proteins. Experiments that compared vagi
nal keratinocyte sensitivity to each agent during a continuous, 48-h exposu
re demonstrated that primary vaginal keratinocytes were almost five times m
ore sensitive to N-9 than to either C31G or SDS. To evaluate the effect of
multiple microbicide exposures on cell viability, primary vaginal keratinoc
ytes were exposed to N-9, C31G, or SDS three times during a 78-h period. In
these experiments, cells were considerably more sensitive to C31G than to
N-9 or SDS at lower concentrations within the range tested. When agent conc
entrations were chosen to result in an endpoint of 25% viability after thre
e daily exposures, each exposure decreased cell viability at the same const
ant rate. When time-dependent sensitivity during a continuous 48-h exposure
was examined, exposure to C31G for 18 h resulted in losses in cell viabili
ty not caused by either N-9 or SDS until at least 24 to 48 h. Cumulatively,
these results reveal important variations in time- and concentration-depen
dent sensitivity to N-9, C31G, or SDS within populations of primary human v
aginal keratinocytes cultured in vitro. These investigations represent init
ial steps toward both in vitro modeling of the vaginal microenvironment and
studies of factors that impact the in vivo efficacy of vaginal topical mic
robicides.